142 related articles for article (PubMed ID: 5689669)
1. Myasthenia gravis: effect of the serum and serum globulin on neuromuscular transmission.
Namba T; Grob D
Neurology; 1968 Mar; 18(3):273. PubMed ID: 5689669
[No Abstract] [Full Text] [Related]
2. Effect of serum and serum globulin of patients with myasthenia gravis on neuromuscular transmission.
Namba T; Grob D
Neurology; 1969 Feb; 19(2):173-84. PubMed ID: 5812611
[No Abstract] [Full Text] [Related]
3. Serum globulin in myasthenia gravis: inhibition of alpha-bungarotoxin binding to acetylcholine receptors.
Almon RR; Andrew CG; Appel SH
Science; 1974 Oct; 186(4158):55-7. PubMed ID: 4421998
[TBL] [Abstract][Full Text] [Related]
4. Neuromuscular transmission in neonatal mice injected with serum globulin of myasthenia gravis patients.
Pagala MK; Tada S; Namba T; Grob D
Neurology; 1982 Jan; 32(1):12-7. PubMed ID: 6275304
[TBL] [Abstract][Full Text] [Related]
5. Effect of antibodies against skeletal muscle constituents on muscle function in rats.
Namba T; Grob D
Rev Can Biol; 1969 Mar; 28(1):9-18. PubMed ID: 5770982
[No Abstract] [Full Text] [Related]
6. Desensitization to acetylcholine at motor end plates in normal humans, patients with myasthenia gravis, and experimental models of myasthenia gravis.
Pagala MK; Namba T; Grob D
Ann N Y Acad Sci; 1981; 377():567-82. PubMed ID: 6951485
[TBL] [Abstract][Full Text] [Related]
7. Myasthenia gravis serum reduces acetylcholine sensitivity in cultured rat myotubes.
Anwyl R; Appel SM; Narahashi T
Nature; 1977 May; 267(5608):262-3. PubMed ID: 865618
[No Abstract] [Full Text] [Related]
8. A reassessment of the neurophysiological evidence for a presynaptic defect in myasthenia gravis.
Bergmans J; Fannes-Breselow CF; Gribomont B
Electromyogr Clin Neurophysiol; 1976; 16(4):337-51. PubMed ID: 187402
[No Abstract] [Full Text] [Related]
9. Effect of sera from seronegative myasthenia gravis patients on neuromuscular junctions.
Sato R; Imamoto S; Utsnomiya I; Chiba T; Taguchi K; Abe K; Tanaka K; Miyatake T
Neurol Sci; 2013 Oct; 34(10):1735-44. PubMed ID: 23389808
[TBL] [Abstract][Full Text] [Related]
10. Clinical and physiological studies of the effect of guanidine of patients with myasthenia gravis.
Brown JC; Johns RJ
Johns Hopkins Med J; 1969 Jan; 124(1):1-8. PubMed ID: 5762895
[No Abstract] [Full Text] [Related]
11. Muscle-specific kinase myasthenia gravis IgG4 autoantibodies cause severe neuromuscular junction dysfunction in mice.
Klooster R; Plomp JJ; Huijbers MG; Niks EH; Straasheijm KR; Detmers FJ; Hermans PW; Sleijpen K; Verrips A; Losen M; Martinez-Martinez P; De Baets MH; van der Maarel SM; Verschuuren JJ
Brain; 2012 Apr; 135(Pt 4):1081-101. PubMed ID: 22396395
[TBL] [Abstract][Full Text] [Related]
12. Myasthenia gravis. Serum globulin bound in vivo to skeletal muscle striations.
Namba T; Sato T; Grob D
Arch Neurol; 1967 Dec; 17(6):637-44. PubMed ID: 4228308
[No Abstract] [Full Text] [Related]
13. Recent evidence on the neuromuscular block in myasthenia gravis.
Desmedt JE; Borenstein S
Electroencephalogr Clin Neurophysiol; 1971 Apr; 30(4):366. PubMed ID: 4103546
[No Abstract] [Full Text] [Related]
14. The role of acetylcholine receptor antibodies in myasthenia gravis.
Appel SH; Elias SB; Chauvin P
Fed Proc; 1979 Sep; 38(10):2381-5. PubMed ID: 478014
[TBL] [Abstract][Full Text] [Related]
15. Pathological mechanisms in experimental autoimmune myasthenia gravis. II. Passive transfer of experimental autoimmune myasthenia gravis in rats with anti-acetylcholine recepotr antibodies.
Lindstrom JM; Engel AG; Seybold ME; Lennon VA; Lambert EH
J Exp Med; 1976 Sep; 144(3):739-53. PubMed ID: 182897
[TBL] [Abstract][Full Text] [Related]
16. Cholinergic neuromuscular hyperactivity in patients with myasthenia gravis seropositive for MuSK antibody.
Punga AR; Flink R; Askmark H; Stålberg EV
Muscle Nerve; 2006 Jul; 34(1):111-5. PubMed ID: 16453324
[TBL] [Abstract][Full Text] [Related]
17. Myasthenia gravis: a serum factor blocking acetylcholine receptors of the human neuromuscular junction.
Bender AN; Ringel SP; Engel WK; Daniels MP; Vogel Z
Lancet; 1975 Mar; 1(7907):607-9. PubMed ID: 47950
[No Abstract] [Full Text] [Related]
18. Halothane-induced variability in the neuromuscular transmission of patients with myasthenia gravis.
Nilsson E; Paloheimo M; Müller K; Heinonen J
Acta Anaesthesiol Scand; 1989 Jul; 33(5):395-401. PubMed ID: 2800976
[TBL] [Abstract][Full Text] [Related]
19. Accelerated degradation of acetylcholine receptor from cultured rat myotubes with myasthenia gravis sera and globulins.
Appel SH; Anwyl R; McAdams MW; Elias S
Proc Natl Acad Sci U S A; 1977 May; 74(5):2130-4. PubMed ID: 266734
[TBL] [Abstract][Full Text] [Related]
20. Single fibre electromyographic studies in myasthenia gravis with repetitive nerve stimulation.
Schwartz MS; Stålberg E
J Neurol Neurosurg Psychiatry; 1975 Jul; 38(7):678-82. PubMed ID: 1159439
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
